ISSN: 1869-6953

Journal Home

Diabetes Therapy Q1 Unclaimed

Springer Publishing Company United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Diabetes Therapy is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism and Internal Medicine with an H index of 47. It is an CC BY-NC Journal with a Double blind peer review review system, and It has a price of 3080 €. The scope of the journal is focused on diabetes, obesity, metabolic syndromes, type 1 diabetes, type 2 diabetes. It has an SJR impact factor of 1,039 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,039.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Endocrinology, Diabetes and Metabolism (Q1) Internal Medicine (Q1)

Price

3080 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,039

SJR Impact factor

47

H Index

137

Total Docs (Last Year)

622

Total Docs (3 years)

5019

Total Refs

2009

Total Cites (3 years)

577

Citable Docs (3 years)

3.48

Cites/Doc (2 years)

36.64

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

The Lancet Diabetes and Endocrinology Q1
Nature Reviews Endocrinology Q1
Endocrine Reviews Q1
Nature Metabolism Q1
Diabetes Care Q1

Compare this journals

Aims and Scope

Diabetes Obesity Metabolic syndromes Type 1 diabetes Type 2 diabetes

Best articles by citations

Efficacy of Insulin Pump Therapy on Diabetes Treatment Satisfaction and Glycemic Control Among Patients with Type 1 Diabetes Mellitus in Saudi Arabia: A Prospective Study

Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes

Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis

Dialing Torque Preferences of People with Diabetes When Using Insulin Pens: A Pilot Study

Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment

Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study

Association Between Maternal Glucose/Lipid Metabolism Parameters and Abnormal Newborn Birth Weight in Gestational Diabetes Complicated by Preeclampsia: A Retrospective Analysis of 248 Cases

Evaluation of Glycaemic Control, Glucose Variability and Hypoglycaemia on Long-Term Continuous Subcutaneous Infusion vs. Multiple Daily Injections: Observational Study in Pregnancies With Pre-Existing Type 1 Diabetes

The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 Diabetes

No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects

Letter from the Editor

Changing Patients' Treatment Preferences and Values with a Decision Aid for Type 2 Diabetes Mellitus: Results from the Treatment Arm of a Randomized Controlled Trial

SHOW MORE ARTICLES

Methodological Tools for Exploring Novel Biopharmaceutical Approaches to the Metabolic Syndrome and Related Disorders

Cardiac Versus Non-Cardiac Related Mortality Following Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis

Development and Validation of a New Diabetes Risk Score in Guyana

SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c - Translating Evidence into Practice

Towards a Physiological Prandial Insulin Profile: Enhancement of Subcutaneously Injected Prandial Insulin Using Local Warming Devices

Safety and Efficacy of Empagliflozin as Add-On Therapy to GLP-1 Receptor Agonist (Liraglutide) in Japanese Patients with Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Parallel-Group Phase 4 Study

A Review of the Safety and Adverse Event Profile of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide

Diabetes Distress or Major Depressive Disorder? A Practical Approach to Diagnosing and Treating Psychological Comorbidities of Diabetes

EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China

Accuracy Evaluation of CONTOUR¬ÆPLUS Compared With Four Blood Glucose Monitoring Systems

Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme

Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials